NS · Pharmaceuticals

Zydus Lifesciences Ltd (ZYDUSLIFE)

Pharmaceuticals & Biotechnology

Zydus Lifesciences Ltd (ZYDUSLIFE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-03, reported market cap is $1.12T, P/E ratio is 31.43, net margin is 30.8%, dividend yield is 0.09%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZYDUSLIFE

Market cap

$1.12T

P/E ratio

31.43

Net margin

30.8%

Dividend yield

0.09%

Zydus Lifesciences Ltd (ZYDUSLIFE) — FAQ

What is Zydus Lifesciences Ltd's market cap?

Zydus Lifesciences Ltd (ZYDUSLIFE) has a reported market cap of $1.12T (data as of 2026-07-03).

What is ZYDUSLIFE's P/E ratio?

The price-to-earnings (P/E) ratio for Zydus Lifesciences Ltd (ZYDUSLIFE) is 31.43 (data as of 2026-07-03).

Does Zydus Lifesciences Ltd pay a dividend?

Zydus Lifesciences Ltd (ZYDUSLIFE) shows a reported dividend yield of 0.09%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-03).

What sector is Zydus Lifesciences Ltd in?

Zydus Lifesciences Ltd (ZYDUSLIFE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is ZYDUSLIFE listed on?

ZYDUSLIFE is listed on NS.

What is Zydus Lifesciences Ltd's net margin?

Zydus Lifesciences Ltd (ZYDUSLIFE) reports a net margin of 30.8% (data as of 2026-07-03).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)